MetaCap

Ascentage Pharma Group International American Depository Shares (AAPG) vs COMPASS Pathways Plc American Depository Shares (CMPS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

COMPASS Pathways Plc American Depository Shares (CMPS) has outperformed Ascentage Pharma Group International American Depository Shares (AAPG) over the past year, gaining 55.7% versus a loss of 60.9%. COMPASS Pathways Plc American Depository Shares is the larger company by market cap ($1.14 billion vs $1.12 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AAPG-60.93%CMPS+55.71%
+207%+66%-74%
Nov 21, 20251 yearNov 20, 2026
AAPG-31.13%CMPS+106.94%
+307%+130%-47%
Jan 20, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AAPG versus CMPS key metrics
MetricAAPGCMPS
Share price$11.97$8.05
Market cap$1.12B$1.14B
1-day change-3.78%-6.94%
YTD return-54.38%+16.67%
1-year return-60.93%+55.71%
5-year return—-75.42%
EPS (TTM)$-2.26$-2.34
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$134.35M—
Net income (latest FY)$-55.54M$-287.86M
Gross margin97.03%—
Net margin-41.34%—
52-week high$33.09$15.87
52-week low$11.97$4.88
Distance from 52-week high-63.83%-49.28%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+271.76%+189.57%
Average volume6.97K3.09M
Shares outstanding93.33M141.71M
Employees828156
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CMPS has outperformed AAPG by 116.6 percentage points over the past year.

About Ascentage Pharma Group International American Depository Shares

AAPG stock →

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation.

Health Care · Biotechnology: Pharmaceutical Preparations · 828 employees

About COMPASS Pathways Plc American Depository Shares

CMPS stock →

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa.

Health Care · Biotechnology: Pharmaceutical Preparations · 156 employees

AAPG vs CMPS FAQ

Which is bigger, Ascentage Pharma Group International American Depository Shares or COMPASS Pathways Plc American Depository Shares?

COMPASS Pathways Plc American Depository Shares (CMPS) is larger, with a market capitalization of $1.14B compared with $1.12B for Ascentage Pharma Group International American Depository Shares (AAPG).

Which stock has performed better over the past year, AAPG or CMPS?

CMPS returned +55.71% over the past 12 months, compared with -60.93% for AAPG (price return, excluding dividends). Past performance does not predict future results.

Are Ascentage Pharma Group International American Depository Shares and COMPASS Pathways Plc American Depository Shares in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons